MMP26 has been associated with tumor development, invasion and metastasis of NSCLC but its methylation profile was not reported [48], our analysis showed it to be highly hypomethylated in Stage II (Table 3). The gene discussed is MMP26; the disease is non-small cell lung carcinoma.